Skip to main navigation
 
Manage Cookie Consent
 
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
 
View preferences
Privacy and Cookie Notice {title} {title}
Quoin Pharmaceuticals, Inc.
  • Home
  • About
    • Who We Are
    • Timeline/History
    • Leadership
    • Board
    • Partners
  • Pipeline
    • Pipeline
    • Indications
    • About Netherton Syndrome
    • Patients & Families
    • Resources
    • Clinical Trial FAQs
  • Investors
    • Company Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Corporate Governance
    • IR Resources
  • Contact


SEC Filing Details

  • Company Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
    • CVR Holders
  • Financial Information
    • SEC Filings
    • Annual Report and Proxy Statement
    • Special Meetings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Officers
    • Committee Composition
    • Board Diversity Matrix
  • IR Resources
    • Email Alerts
    • Contact IR

Document Details

Form
EFFECT
Filing Date
Feb 10, 2023
Document Date
Feb 10, 2023
Form Description
EFFECT
Filing Group
Other
Company
Quoin Pharmaceuticals, Inc.
Issuer
QUOIN PHARMACEUTICALS, LTD.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Quoin Pharmaceuticals, Inc. Logo

Subscribe

Sign up for alerts to stay up to date on Quoin Pharmaceuticals.

News:

Dec 20, 2024

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

Dec 19, 2024

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

2024 © Quoin Pharmaceuticals, Inc. Privacy Policy
  • Linkedin
  • Twitter